NEW DELHI – The WHO has rapped yet another Indian clinical research organization (CRO) for "critical lapses and major deviations" during the conduct of clinical trials, bringing the spotlight back to the need for Indian pharma firms and CROs to pull up their socks over stringent adherence to trial protocols.
NEW DELHI – The Indian pharma industry is struggling with data integrity issues that repeatedly crop up during inspections by global regulators; they are tarnishing the industry's reputation while undermining global confidence in Indian products.
NEW DELHI – The Indian pharma industry is struggling with data integrity issues that repeatedly crop up during inspections by global regulators; they are tarnishing the industry's reputation while undermining global confidence in Indian products.
NEW DELHI – The WHO has rapped yet another Indian clinical research organization (CRO) for "critical lapses and major deviations" during the conduct of clinical trials, bringing the spotlight back to the need for Indian pharma firms and CROs to pull up their socks over stringent adherence to trial protocols.
NEW DELHI – A new report to the government of India suggests the adoption of a slew of measures to help domestic pharma firms, especially small firms that form the bulk of the industry, better understand the global regulatory landscape and meet compliance standards in advanced countries.
NEW DELHI – A new report to the government of India suggests the adoption of a slew of measures to help domestic pharma firms, especially small firms that form the bulk of the industry, better understand the global regulatory landscape and meet compliance standards in advanced countries.
NEW DELHI – India has launched a pharmaceutical price databank to be managed and operated by its drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), to help consumers make informed product formulation and rate choices.
NEW DELHI – India has launched a pharmaceutical price databank to be managed and operated by its drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), to help consumers make informed product formulation and rate choices.
